Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Rachel Zeng, Stefanie Glaubitz & Jens Schmidt. (2021) Inflammatory myopathies: shedding light on promising agents and combination therapies in clinical trials. Expert Opinion on Investigational Drugs 30:11, pages 1125-1140.
Read now
Read now
Nancy Ho-Mahler, Beni Turner, Michael Eaddy, Mark L Hanke & Winnie W Nelson. (2020) Treatment with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Dermatomyositis/Polymyositis. Open Access Rheumatology: Research and Reviews 12, pages 21-28.
Read now
Read now
Tanya Chandra & Rohit Aggarwal. (2020) Clinical trials and novel therapeutics in dermatomyositis. Expert Opinion on Emerging Drugs 25:3, pages 213-228.
Read now
Read now
Hirokazu Sasaki & Hitoshi Kohsaka. (2018) Current diagnosis and treatment of polymyositis and dermatomyositis. Modern Rheumatology 28:6, pages 913-921.
Read now
Read now
Verena Isak & Joseph L. Jorizzo. (2018) Recent developments on treatment strategies and the prognosis of dermatomyositis: a review. Journal of Dermatological Treatment 29:5, pages 450-459.
Read now
Read now
Tyler Knight, T Christopher Bond, Breanna Popelar, Li Wang, John W Niewoehner, Kathryn Anastassopoulos & Michael Philbin. (2017) Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab. ClinicoEconomics and Outcomes Research 9, pages 271-279.
Read now
Read now
Siamak Moghadam-Kia, Rohit Aggarwal & Chester V Oddis. (2015) Treatment of inflammatory myopathy: emerging therapies and therapeutic targets. Expert Review of Clinical Immunology 11:11, pages 1265-1275.
Read now
Read now
Articles from other publishers (36)
Tanya Chandra & Rohit Aggarwal. (2023) A Narrative Review of Acthar Gel for the Treatment of Myositis. Rheumatology and Therapy 10:3, pages 523-537.
Crossref
Crossref
George Iliopoulos & Dimitrios Daoussis. (2023) FDA-APPROVED INDICATIONS OF ADRENOCORTICOTROPIC HORMONE (ACTH) AS A DRUG: DOES IT HAVE A PLACE IN DISEASE MANAGEMENT TODAY?. Central Asian Journal of Medical Hypotheses and Ethics 3:4, pages 220-231.
Crossref
Crossref
Yael Sharon, Stephen D. Anesi, Christine E. Martinez, Andrew J. W. Huang, Charles Stephen Foster & David S. Chu. (2022) Repository Corticotropin Injection as an Alternative Treatment for Refractory Ocular Mucous Membrane Pemphigoid. Cornea 41:1, pages 45-51.
Crossref
Crossref
Rohan Bir Singh, Shruti Sinha, Chhavi Saini, Elsayed Elbasiony, Sahil Thakur & Aniruddha Agarwal. (2020) Recent advances in the management of non-infectious posterior uveitis. International Ophthalmology 40:11, pages 3187-3207.
Crossref
Crossref
Edward Chen, Hoyt Harris Reynolds & Lauren V. Graham. (2020) Ocular cicatricial pemphigoid treated with intramuscular corticotropin injections. JAAD Case Reports 6:5, pages 450-452.
Crossref
Crossref
Stefanie Glaubitz, Rachel Zeng & Jens Schmidt. (2020) New insights into the treatment of myositis. Therapeutic Advances in Musculoskeletal Disease 12, pages 1759720X1988649.
Crossref
Crossref
Chester V. Oddis & Rohit Aggarwal. 2020. Managing Myositis. Managing Myositis
275
283
.
Anjali Patwardhan & Charles H. Spencer. (2019) Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon. Pediatric Rheumatology 17:1.
Crossref
Crossref
Yael Sharon & David S. Chu. (2019) Adrenocorticotropic hormone gel for patients with non-infectious uveitis. American Journal of Ophthalmology Case Reports 15, pages 100502.
Crossref
Crossref
Muhammad Hassan, Samendra Karkhur, Jeong H. Bae, Muhammad S. Halim, Maria S. Ormaechea, Neil Onghanseng, Nam V. Nguyen, Rubbia Afridi, Yasir J. Sepah, Diana V. Do & Quan D. Nguyen. (2019) New therapies in development for the management of non‐infectious uveitis: A review. Clinical & Experimental Ophthalmology 47:3, pages 396-417.
Crossref
Crossref
Rohit Aggarwal & Chester V Oddis. (2019)
Response to: ’Elephant in the room' by Hartung
et al
. Annals of the Rheumatic Diseases 78:2, pages e12-e12.
Crossref
Crossref
Simone Barsotti & Ingrid E. Lundberg. (2018) Current Treatment for Myositis. Current Treatment Options in Rheumatology 4:4, pages 299-315.
Crossref
Crossref
Namita A. Goyal & Tahseen Mozaffar. (2018) Novel Therapeutic Options in Treatment of Idiopathic Inflammatory Myopathies. Current Treatment Options in Neurology 20:9.
Crossref
Crossref
Yael Sharon & David S. Chu. (2018) Adrenocorticotropic hormone analogue as novel treatment regimen in ocular cicatricial pemphigoid. American Journal of Ophthalmology Case Reports 10, pages 264-267.
Crossref
Crossref
Rohit Aggarwal, Galina Marder, Diane Carol Koontz, Preeya Nandkumar, Zengbiao Qi & Chester V Oddis. (2018) Efficacy and safety of adrenocorticotropic hormone gel in refractory dermatomyositis and polymyositis. Annals of the Rheumatic Diseases 77:5, pages 720-727.
Crossref
Crossref
Chester V. Oddis & Rohit Aggarwal. (2018) Treatment in myositis. Nature Reviews Rheumatology 14:5, pages 279-289.
Crossref
Crossref
Winnie W. Nelson, Michael J. Philbin, Jack R. Gallagher, Kylee Heap, Susan Carroll & George J. Wan. (2017) A Retrospective Medical Record Review of Utilization Patterns and Medical Resource Use Associated with Repository Corticotropin Injection among Patients with Rheumatologic Diseases in the United States. Rheumatology and Therapy 4:2, pages 465-474.
Crossref
Crossref
Valérie Leclair & Ingrid E. Lundberg. (2017) Recent clinical trials in idiopathic inflammatory myopathies. Current Opinion in Rheumatology 29:6, pages 652-659.
Crossref
Crossref
Lorenzo Cavagna, Sara Monti, Roberto Caporali, Mariele Gatto, Luca Iaccarino & Andrea Doria. (2017) How I treat idiopathic patients with inflammatory myopathies in the clinical practice. Autoimmunity Reviews 16:10, pages 999-1007.
Crossref
Crossref
Gihyun Myung, Winnie W. Nelson & Maureen A. McMahon. (2017) Effects of Repository Corticotropin Injection on Medication Use in Patients With Rheumatologic Conditions: A Claims Data Study. Journal of Pharmacy Technology 33:4, pages 151-155.
Crossref
Crossref
Michael Philbin, John Niewoehner & George J. Wan. (2017) Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications. Advances in Therapy 34:8, pages 1775-1790.
Crossref
Crossref
Ilaria Pagnini, Antonio Vitale, Carlo Selmi, Rolando Cimaz & Luca Cantarini. (2015) Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms. Clinical Reviews in Allergy & Immunology 52:1, pages 34-44.
Crossref
Crossref
Aniruddha Agarwal, Muhammad Hassan, Yasir J. Sepah, Diana V. Do & Quan Dong Nguyen. (2016) Subcutaneous repository corticotropin gel for non-infectious panuveitis: Reappraisal of an old pharmacologic agent. American Journal of Ophthalmology Case Reports 4, pages 78-82.
Crossref
Crossref
C. V. Oddis. (2016) Update on the pharmacological treatment of adult myositis. Journal of Internal Medicine 280:1, pages 63-74.
Crossref
Crossref
Ritu Lal, Stacie Bell, Rashida Challenger, Vakessa Hammock, Mary Nyberg, Dima Decker, Patrice M. Becker & David Young. (2015) Pharmacodynamics and tolerability of repository corticotropin injection in healthy human subjects: A comparison with intravenous methylprednisolone. The Journal of Clinical Pharmacology 56:2, pages 195-202.
Crossref
Crossref
Aarat Patel, Georgia Seely & Rohit Aggarwal. (2016) Repository Corticotropin Injection for Treatment of Idiopathic Inflammatory Myopathies. Case Reports in Rheumatology 2016, pages 1-4.
Crossref
Crossref
Ying Zhou, Elyse E. Lower, Huiping Li & Robert P. Baughman. (2016) Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel. Respiratory Medicine Case Reports 17, pages 5-7.
Crossref
Crossref
Merrilee Needham & Frank L. Mastaglia. (2015) Immunotherapies for Immune-Mediated Myopathies: A Current Perspective. Neurotherapeutics 13:1, pages 132-146.
Crossref
Crossref
B. Volc-Platzer. (2015) Dermatomyositis – updateDermatomyositis—update. Der Hautarzt 66:8, pages 604-610.
Crossref
Crossref
Jonathan Jones & Robert Wortmann. (2015) Idiopathic inflammatory myopathies—a review. Clinical Rheumatology 34:5, pages 839-844.
Crossref
Crossref
Siamak Moghadam-Kia, Chester V Oddis & Rohit Aggarwal. (2014) Update on the treatment of myositis. International Journal of Clinical Rheumatology 9:5, pages 505-518.
Crossref
Crossref
JJ Fiechtner & T Montroy. (2014) Treatment of moderately to severely active systemic lupus erythematosus with adrenocorticotropic hormone: a single-site, open-label trial. Lupus 23:9, pages 905-912.
Crossref
Crossref
Lisa G. Rider, James D. Katz & Olcay Y. Jones. (2013) Developments in the Classification and Treatment of the Juvenile Idiopathic Inflammatory Myopathies. Rheumatic Disease Clinics of North America 39:4, pages 877-904.
Crossref
Crossref
A.D. Keck & U.A. Walker. (2013) Therapie der MyositidenTherapy of myositis. Zeitschrift für Rheumatologie 72:3, pages 227-235.
Crossref
Crossref
Rohit Aggarwal & Chester V. Oddis. (2012) Therapeutic advances in myositis. Current Opinion in Rheumatology 24:6, pages 635-641.
Crossref
Crossref
Antonietta Citterio, Loredana La Mantia, Gabriele Ciucci, Livia Candelise, Fabio Brusaferri, Rune Midgard & Graziella Filippini. (2000) Corticosteroids or ACTH for acute exacerbations in multiple sclerosis. Cochrane Database of Systematic Reviews.
Crossref
Crossref